Download PDF
Klin Monbl Augenheilkd 2003; 220(8): 526-531
DOI: 10.1055/s-2003-41871
Übersicht
© Georg Thieme Verlag Stuttgart · New York

Die diabetische Makulopathie - Klinik und Therapie

Diabetic Maculopathy - Classification and TherapySascha  Fauser1 , Tim  U.  Krohne1 , Bernd  Kirchhof1 , Antonia  M.  Joussen1
  • 1Abteilung für Netzhaut- und Glaskörperchirurgie des Zentrums für Augenheilkunde und Zentrum für Molekulare Medizin (ZMMK), Universität zu Köln
Gefördert durch DFG Jo 324/4-1, Jo 324/6-1, ZMMK Köln (TV76), Ernst und Berta Grimmke Stiftung und Gertrud und Werner Müller Stiftung
Further Information

Publication History

Eingegangen: 10. Juni 2003

Angenommen: 14. Juli 2003

Publication Date:
03 September 2003 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Im Hinblick auf die Therapie der Makulopathie scheint die derzeit gängige klinische Einteilung in die fokale, diffuse und ischämische Makulopathie sinnvoll. Die vorliegende Zusammenfassung diskutiert den Einsatz therapeutischer Standardverfahren sowie der in jüngster Zeit zunehmenden chirurgischen und pharmakologischen Möglichkeiten.

Abstract

The current clinical classification into focal, diffuse, and ischaemic maculopathy is useful with respect to pathomechanism and therapy. This review discusses the value of standard therapeutical options as well as the recent surgical and pharmacological approaches.

Schlüsselwörter

Diabetische Retinopathie - diabetische Makulopathie - klinische Einteilung - Lasertherapie - ILM-Peeling - Triamcinolon

Key words

Diabetic retinopathy - diabetic maculopathy - clinical classification - laser therapy - ILM peeling - triamcinolone

Literatur

  • 1 Aiello L M, Ferris F L. Photocoagulation for diabetic macular edema.  Arch Ophthalmol. 1987;  105 1163
    PubMedGoogle Scholar
  • 2 Akduman L, Olk R J. Laser photocoagulation of diabetic macular edema.  Ophthalmic Surg Lasers. 1997;  28 387-408
    PubMedGoogle Scholar
  • 3 Antonetti D A, Wolpert E B, DeMaio L, Harhaj N S, Scaduto R C. Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin.  J Neurochem. 2002;  80 667-677
    CrossrefPubMedGoogle Scholar
  • 4 Bailey C C, Sparrow J M, Grey R H, Cheng H. The National Diabetic Retinopathy Laser Treatment Audit. III. Clinical outcomes.  Eye. 1999;  13 151-159
    CrossrefPubMedGoogle Scholar
  • 5 Bertram B, Arens C DH. Leitlinie Nr. 20: Diabetische Retinopathie. In: Bertram B, Arens CDM (Hrsg) Praxisorientierte Handlungsleitlinien für Diagnose und Therapie in der Augenheilkunde. Düsseldorf; Berufsverband der Augenärzte Deutschlands 1998
    Google Scholar
  • 6 Blankenship G W. Diabetic macular edema and argon laser photocoagulation: a prospective randomized study.  Ophthalmology. 1979;  86 69-78
    PubMedGoogle Scholar
  • 7 Bresnick G H, Venecia G de, Myers F L, Harris J A, Davis M D. Retinal ischemia in diabetic retinopathy.  Arch Ophthalmol. 1975;  93 1300-1310
    PubMedGoogle Scholar
  • 8 Bresnick G H. Diabetic macular edema. A review.  Ophthalmology. 1986;  93 989-997
    PubMedGoogle Scholar
  • 9 Bresnick G H. Diabetic maculopathy. A critical review highlighting diffuse macular edema.  Ophthalmology. 1983;  90 1301-1317
    PubMedGoogle Scholar
  • 10 Caird F I, Hutchinson M, Pirie A. Cataract extraction and diabetes.  Br J Ophthalmol. 1965;  49 466-471
    PubMedGoogle Scholar
  • 11 Cardillo Piccolino F, Zingirian M, Mosci C. Classification of proliferative diabetic retinopathy.  Graefes Arch Clin Exp Ophthalmol. 1987;  225 245-250
    PubMedGoogle Scholar
  • 12 Early Treatment Diabetic Retinopathy Study Research Group . Early photocoagulation for diabetic retinopathy. ETDRS report number 9.  Ophthalmology. 1991;  98 766-785
    CrossrefPubMedGoogle Scholar
  • 13 Fong D S, Segal P P, Myers F, Ferris F L, Hubbard L D, Davis M D. Subretinal fibrosis in diabetic macular edema. ETDRS report 23. Early Treatment Diabetic Retinopathy Study Research Group.  Arch Ophthalmol. 1997;  115 873-877
    CrossrefPubMedGoogle Scholar
  • 14 Gandorfer A, Messmer E M, Ulbig M W, Kampik A. Resolution of diabetic macular edema after surgical removal of posterior hyaloid and the inner limiting membrane.  Retina. 2000;  20 126-133
    CrossrefPubMedGoogle Scholar
  • 15 Garner A. Histopathology of diabetic retinopathy in man.  Eye. 1993;  7 250-253
    PubMedGoogle Scholar
  • 16 Global Diabetic Retinopathy Project Group .International clinical diabetic macular edema disease severity scale. 2002
    Google Scholar
  • 17 Grey R H. The treatment of diabetic maculopathy by argon laser photocoagulation.  Trans Ophthalmol Soc U K. 1986;  105 424-429
    PubMedGoogle Scholar
  • 18 Hammes H P, Bertram B, Bornfeld N, Gandjour A, Parandeh-Shab F, Danne D, Kroll P, Lemmen K D, Look D. Diagnostik, Therapie und Verlaufskontrolle der diabetischen Retinopathie und Makulopathie. In: Scherbaum WA, Lauterbach KW, Renner R (Hrsg) Evidenzbasierte Diabetes-Leitlinien DDG. 1. Auflage. Deutsche Diabetes-Gesellschaft 2000
    Google Scholar
  • 19 The Diabetic Retinopathy Study Research Group . Indications for photocoagulation treatment of diabetic retinopathy: Diabetic Retinopathy Study Report no. 14.  Int Ophthalmol Clin. 1987;  27 239-253
    PubMedGoogle Scholar
  • 20 Isenberg S J, Apt L, Yoshimori R, Khwarg S. Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic.  Arch Ophthalmol. 1985;  103 1340-1342
    CrossrefPubMedGoogle Scholar
  • 21 Jaffe G J, Burton T C. Progression of nonproliferative diabetic retinopathy following cataract extraction.  Arch Ophthalmol. 1988;  106 745-749
    PubMedGoogle Scholar
  • 22 Jonas J B, Kreissig I, Sofker A, Degenring R F. Intravitreal injection of triamcinolone for diffuse diabetic macular edema.  Arch Ophthalmol. 2003;  121 57-61
    PubMedGoogle Scholar
  • 23 Jonas J B, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema.  Am J Ophthalmol. 2001;  132 425-427
    CrossrefPubMedGoogle Scholar
  • 24 Kadonosono K, Itoh N, Ohno S. Perifoveal microcirculation before and after vitrectomy for diabetic cystoid macular edema.  Am J Ophthalmol. 2000;  130 740-744
    CrossrefPubMedGoogle Scholar
  • 25 Klein R, Klein B E, Moss S E, Davis M D, DeMets D L. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema.  Ophthalmology. 1984;  91 1464-1474
    CrossrefPubMedGoogle Scholar
  • 26 Klein R, Klein B E, Moss S E. Visual impairment in diabetes.  Ophthalmology. 1984;  91 1-9
    PubMedGoogle Scholar
  • 27 Ladas I D, Theodossiadis G P. Long-term effectiveness of modified grid laser photocoagulation for diffuse diabetic macular edema.  Acta Ophthalmol (Copenh). 1993;  71 393-397
    PubMedGoogle Scholar
  • 28 Lee C M, Olk R J. Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results.  Ophthalmology. 1991;  98 1594-1602
    PubMedGoogle Scholar
  • 29 Lemmen K D, Ulbig M W, Bornfeld N, Bertram B, Gerke E H. Initiativgruppe Früherkennung diabetischer Augenerkrankungen: Stadieneinteilung und Therapie der diabetischen Retinopathie und Makulopathie, Report No. 3. Heidelberg; Kaden 2001
    Google Scholar
  • 30 Martidis A, Duker J S, Greenberg P B, Rogers A H, Puliafito C A, Reichel E. et al . Intravitreal triamcinolone for refractory diabetic macular edema.  Ophthalmology. 2002;  109 920-927
    CrossrefPubMedGoogle Scholar
  • 31 McDonald H R, Schatz H. Macular edema following panretinal photocoagulation.  Retina. 1985;  5 5-10
    PubMedGoogle Scholar
  • 32 McNaught E I, Foulds W S, Allan D. Grid photocoagulation improves reading ability in diffuse diabetic macular oedema.  Eye. 1988;  2 288-296
    PubMedGoogle Scholar
  • 33 Meyers S M. Macular edema after scatter laser photocoagulation for proliferative diabetic retinopathy.  Am J Ophthalmol. 1980;  90 210-216
    PubMedGoogle Scholar
  • 34 Olk R J. Argon green (514 nm) versus krypton red (647 nm) modified grid laser photocoagulation for diffuse diabetic macular edema.  Ophthalmology. 1990;  97 1101-1112; discussion 1112 - 1113
    PubMedGoogle Scholar
  • 35 Olk R J. Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema.  Ophthalmology. 1986;  93 938-950
    PubMedGoogle Scholar
  • 36 Early Treatment Diabetic Retinopathy Study research group . Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1.  Arch Ophthalmol. 1985;  103 1796-1806
    CrossrefPubMedGoogle Scholar
  • 37 Early Treatment Diabetic Retinopathy Study Research Group . Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study Report no. 4.  Int Ophthalmol Clin. 1987;  27 265-272
    CrossrefPubMedGoogle Scholar
  • 38 Schatz H, Atienza D, McDonald H R, Johnson R N. Severe diabetic retinopathy after cataract surgery.  Am J Ophthalmol. 1994;  117 314-321
    PubMedGoogle Scholar
  • 39 Schatz H, Madeira D, McDonald H R, Johnson R N. Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema.  Arch Ophthalmol. 1991;  109 1549-1551
    CrossrefPubMedGoogle Scholar
  • 40 Straatsma B R, Pettit T H, Wheeler N, Miyamasu W. Diabetes mellitus and intraocular lens implantation.  Ophthalmology. 1983;  90 336-343
    PubMedGoogle Scholar
  • 41 Tachi N, Ogino N. Long-term follow-up of grid photocoagulation for diffuse macular edema associated with diabetic retinopathy.  Folia Ophthalmol Jpn. 1996;  47 1252-1256
    PubMedGoogle Scholar
  • 42 Ballegooie E van, Everdingen J J van. CBO guidelines on diagnosis, treatment, and prevention of complication in diabetes mellitus: retinopathy, foot ulcers, nephropathy and cardiovascular diseases. Dutch Institute for Quality Assurance.  Ned Tijdschr Geneeskd. 2000;  144 413-418
    PubMedGoogle Scholar
  • 43 Wallow I H. Repair of the pigment epithelial barrier following photocoagulation.  Arch Ophthalmol. 1984;  102 126-135
    PubMedGoogle Scholar
  • 44 Watanabe M, Oshima Y, Emi K. Optical cross-sectional observation of resolved diabetic macular edema associated with vitreomacular separation.  Am J Ophthalmol. 2000;  129 264-267
    CrossrefPubMedGoogle Scholar
  • 45 Weiter J J, Zuckerman R. The influence of the photoreceptor-RPE complex on the inner retina. An explanation for the beneficial effects of photocoagulation.  Ophthalmology. 1980;  87 1133-1139
    PubMedGoogle Scholar
  • 46 Whitelocke R A, Kearns M, Blach R K, Hamilton A M. The diabetic maculopathies.  Trans Ophthalmol Soc U K. 1979;  99 314-320
    PubMedGoogle Scholar
  • 47 Zander E, Herfurth S, Bohl B, Heinke P, Herrmann U, Kohnert K D. et al . Maculopathy in patients with diabetes mellitus type 1 and type 2: associations with risk factors.  Br J Ophthalmol. 2000;  84 871-876
    CrossrefPubMedGoogle Scholar

PD Dr. Antonia M. Joussen

Abteilung für Netzhaut- und Glaskörperchirurgie · Zentrum für Augenheilkunde

Joseph-Stelzmann-Straße 9

50931 Köln

Email: JoussenA@aol.com

URL: http://www.retina-cologne.de

      >